The dialysis encephalopathy syndrome. Possible aluminum intoxication
- PMID: 1244532
- DOI: 10.1056/NEJM197601222940402
The dialysis encephalopathy syndrome. Possible aluminum intoxication
Abstract
The aluminum content of muscle, bone and brain was measured in control subjects and in uremic patients on dialysis who had been maintained on phosphate-binding aluminum gels. The mean muscle aluminum was 14.8 ppm, and the trabecular-bone aluminum 98.5 ppm in the patients on dialysis, as compared with 1.2 and 2.4 in control subjects (P less than 0.05). Brain gray-matter aluminum values in a group of uremic patients on dialysis who died of a neurologic syndrome of unknown cause were 25 ppm as compared with 6.5 ppm in a group of uremic patients on dialysis who died of other causes and 2.2 ppm in control subjects. The fact that brain gray-matter aluminum was higher in all patients with the dialysis-associated encephalopathy syndrome than any of the control subjects or other uremic patients on dialysis suggests that this syndrome may be due to aluminum in intoxication.
Similar articles
-
Aluminum metabolism and toxicity in uremia.J UOEH. 1987 Mar 20;9 Suppl:123-32. J UOEH. 1987. PMID: 3602743 No abstract available.
-
Early deposition of aluminum in bone in diabetic patients on hemodialysis.N Engl J Med. 1987 Feb 5;316(6):292-6. doi: 10.1056/NEJM198702053160602. N Engl J Med. 1987. PMID: 3807961
-
Dialysis encephalopathy.Clin Nephrol. 1985;24 Suppl 1:S15-9. Clin Nephrol. 1985. PMID: 3915955 Review.
-
[Development of dialysis encephalopathy in the context of rubidium and aluminum levels in the blood and cerebral cortex of patients with concomitant uremic polyneuropathy on long-term dialysis].Przegl Lek. 1987;44(3):309-14. Przegl Lek. 1987. PMID: 3615935 Polish. No abstract available.
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
Cited by
-
The Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial.Am J Kidney Dis. 2015 Sep;66(3):479-88. doi: 10.1053/j.ajkd.2015.03.013. Epub 2015 May 7. Am J Kidney Dis. 2015. PMID: 25958079 Free PMC article. Clinical Trial.
-
Adynamic bone disease-bone and beyond.NDT Plus. 2008 Jun;1(3):135-47. doi: 10.1093/ndtplus/sfn040. NDT Plus. 2008. PMID: 25983860 Free PMC article. No abstract available.
-
Differentiated neuroblastoma cells are more susceptible to aluminium toxicity than developing cells.Arch Toxicol. 1989;63(3):231-7. doi: 10.1007/BF00316374. Arch Toxicol. 1989. PMID: 2764711
-
Serum aluminium levels of intensive care patients treated with two different antacids for prevention of stress ulceration.Intensive Care Med. 1989;15(2):84-6. doi: 10.1007/BF00295982. Intensive Care Med. 1989. PMID: 2785545 Clinical Trial.
-
Dialysis dementia: recovery after transplantation.Br Med J. 1977 Sep 17;2(6089):740. doi: 10.1136/bmj.2.6089.740. Br Med J. 1977. PMID: 334334 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources